Stocktoria
Compass Therapeutics, Inc. CMPX
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-11-13
Compass Therapeutics, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,613,637 | $6.6M | 3.71% |
| CITADEL ADVISORS LLC | 891,110 | $4.7M | 0.5% |
| MILLENNIUM MANAGEMENT LLC | 846,220 | $4.5M | 0.47% |
| AQR CAPITAL MANAGEMENT LLC | 200,428 | $1.1M | 0.11% |
| D. E. Shaw & Co., Inc. | 65,967 | $348,965 | 0.04% |
| TWO SIGMA INVESTMENTS, LP | 33,100 | $175,099 | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.